N/A
93.116
This program assists State, local health agencies, political subdivisions, and other government entities to conduct TB preventive health service programs to assist in carrying out tuberculosis (TB) control activities designed to prevent transmission of infection and disease. Financial assistance is provided to TB programs to ensure that the program needs for core TB prevention and control activities, human resource development and public health laboratories are met. In addition, objectives include: finding all cases of active tuberculosis and ensuring completion of therapy; finding and screening persons who have had contact with TB patients, evaluating them for TB infection and disease, and ensuring completion of appropriate treatment; and conducting TB surveillance and TB public health laboratory activities that are essential to addressing these priorities. Each of these core activities (completion of therapy, contact investigation, TB surveillance, and TB laboratory activities) is essential to effective TB prevention and control.
This chart shows obligations for the program by fiscal year. All data for this chart was provided by the
administering agency and sourced from SAM.gov, USASpending.gov, and Treasury.gov.
For more information on each of these data sources, please see the
About the data page.
It is estimated that support will continue as provided in fiscal year 2015. Fiscal Year 2016: objectives have been met. Support continued for the 61 tuberculosis (TB) and laboratory cooperative agreements with continued special emphasis on the completion of treatment, contact investigation, and targeted testing of high-risk populations. In addition, funding continued for six awards to support cross-cutting and disease-specific activities, including the prevention and control of HIV, viral hepatitis, STDs, and TB through prevention programs, capacity building for laboratory services, surveillance, human resources and organizational development, and monitoring and evaluation in the US Pacific Islands. Funding was also awarded to expand latent TB investigation testing and treatment to persons within a defined high-risk community in partnership with State and local health departments, community medical providers, and community leader and organizations.
To assist with current efforts of state, local and territorial TB Programs to prevent, control, and eventually eliminate tuberculosis (TB) support continued for the 61 jurisdictions with continued special emphasis on the completion of treatment, contact investigation, and targeted testing of high-risk populations. In addition, funding was awarded to six recipients to support cross-cutting and disease-specific activities, including the prevention and control of HIV, viral hepatitis, STDs, and TB through prevention programs, capacity building for laboratory services, surveillance, human resources and organizational development, and monitoring and evaluation in the US Pacific Islands. Funding was also awarded to expand latent TB investigation testing and treatment to persons within a defined high-risk community in partnership with State and local health departments, community medical providers, and community leader and organizations.
To assist with current efforts of state, local and territorial TB Programs to prevent, control, and eventually eliminate tuberculosis (TB) direct assistance (including emergency drugs) will be provided and support will continue as in fiscal year 2017.
It is estimated that support will continue as provided in fiscal year 2018.
Single Audit Applies (2 CFR Part 200 Subpart F):
For additional information on single audit requirements for this program, review the current Compliance Supplement.
OMB is working with the U.S. Government Accountability Office (GAO) and agency offices of inspectors general to include links to relevant oversight reports. This section will be updated once this information is made available.